Response to: Correspondence on ‘Adalimumab serum concentration to choose a subsequent biological DMARD in patients with rheumatoid arthritis (ADDORA-switch)’
Response to: Correspondence on ‘Adalimumab serum concentration to choose a subsequent biological DMARD in patients with rheumatoid arthritis (ADDORA-switch)’. // Appetite. – URL: https://www.sciencedirect.com/science/article/pii/S0003496726038227?dgcid=rss_sd_all
Response to: Correspondence on ‘Adalimumab serum concentration to choose a subsequent biological DMARD in patients with rheumatoid arthritis (ADDORA-switch)’. Appetite. https://www.sciencedirect.com/science/article/pii/S0003496726038227?dgcid=rss_sd_all
“Response to: Correspondence on ‘Adalimumab serum concentration to choose a subsequent biological DMARD in patients with rheumatoid arthritis (ADDORA-switch)’.” Appetite.
@article{article3571,
title = {Response to: Correspondence on ‘Adalimumab serum concentration to choose a subsequent biological DMARD in patients with rheumatoid arthritis (ADDORA-switch)’},
journal = {Appetite},
url = {https://www.sciencedirect.com/science/article/pii/S0003496726038227?dgcid=rss_sd_all}
}
Publication date: January 2027 Source: Journal of Medical Imaging and Radiation Sciences, Volume 58, Issue 1 Author(s): Moulay Ali Nassiri, Narjes Moghadam, Ariane-Sophie Painchaud-Bouchard, Intissar Hadouch, Madan M. Rehani
Publication date: January 2027 Source: Journal of Medical Imaging and Radiation Sciences, Volume 58, Issue 1 Author(s): Marilack Viana D´Assunção Marques Loureiro, Renata Christian Martins Felix